✦ LIBER ✦

Etoposide, doxorubicin (Adriamycin) and cisplatin regimen in advanced gastric adenocarcinoma: experience with a lower dose schedule

✍ Scribed by Vittorio Gebbia; Roberto Valenza; Antonio Testa; Carmelo Sciume; Antonio Longo; Calogero Cipolla; Nicola Borsellino; Pietro Leo; Mario Latteri; Matteo Florena; Nicola Gebbia

Book ID: 112498807
Publisher: Springer-Verlag
Year: 1994
Tongue: English
Weight: 324 KB
Volume: 120
Category: Article
ISSN: 1432-1335
DOI: 10.1007/bf01221033

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FEP regimen (epidoxorubicin, etoposide a

FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study

✍ Bajetta, E; Di Bartolomeo, M; Carnaghi, C; Buzzoni, R; Mariani, L; Gebbia, V; Co 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 1009 KB

A phase I/II study of a stepwise dose-es

A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours

✍ Bokemeyer, C.; Schmoll, H.-J.; Harstrick, A.; Illiger, H.J.; Metzner, B.; Räth, 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 929 KB

The combination of cisplatin, doxorubici

The combination of cisplatin, doxorubicin, and mitomycin (PAM) compared with the FAM regimen in treating advanced gastric carcinoma: A phase II randomized trial of the Italian oncology group for clinical research

✍ Vincenzo De Lisi; Giorgio Cocconi; Francesco Angelini; Francesco Cavicchi; Franc 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB 👁 2 views

## BACKGROUND. In a randomized Phase I1 study, the authors evaluated the activity and toxicity of the new cisplatin, doxorubicin, and mitomycin C (PAM) comhination, that includes cisplatin (P) instead of 5-fluorouracil as in the 5-fluorouracil, doxorubicin, and mitomycin C (FAM) Combination, in pat